Journal of Transcatheter Valve Therapies (JTVT) is a peer-reviewed, open access journal publishing articles on Transcatheter Valve Therapies. Published continuously online, the journal is fully indexed in J-STAGE. JTVT welcomes submissions from around the world.
About the journal
Journal of Transcatheter Valve Therapies is an official journal of Japan Transcatheter Valve Therapies (Society) .
Instructions to Authors
Journal of Transcatheter Valve Therapies supplies comprehensive and clear Instructions to Authors, which offer guidance on article types and format, journal policies, and how to submit manuscripts.
The journal welcomes submissions from around the world. Please consult the Instructions to Authors and the Author Checklist.
Latest articlesView more articles >
Original ArticleFebruary 22, 2024
Objective: To investigate reverse cardiac remodeling in self-expandable valve (SEV) and balloon-expandable valve (BEV) in patients with low-flow, low-gradient aortic stenosis (LFLGAS) who performed transcatheter aortic valve replacement (TAVR).
Original ArticleFebruary 2, 2024
Objective: Transcatheter edge-to-edge repair (TEER) using MitraClip (Abbott, Abbott Park, IL, USA) is a less invasive treatment for patients with mitral regurgitation (MR) than mitral valve surgery. Treatment strategies for degenerative MR tend to be individually influenced by the anatomical characteristics of the lesion and patient background, and the middle- to long-term clinical outcomes of TEER with MitraClips, including the fourth-generation (G4) system, are unclear. This study aimed to evaluate the middle-term clinical outcomes of TEER for degenerative MR based on actual clinical practice.
ReviewJanuary 23, 2024
Severe tricuspid regurgitation (TR) is now widely thought of as a significant contributor to cardiac morbidity and mortality. Neither medical therapy nor conventional surgery is efficacious for most patients. In contrast, with the rapid development of transcatheter tricuspid valve therapies, TR can now be corrected without incurring the risks of conventional surgery, and it is showing promise to improve quality of life and mortality. In this review, we discuss transcatheter tricuspid valve interventions (TTVIs), the current status of clinical trials in the United States, TTVI devices we have used, and our experience.